Reduced exposure of infants to allergens in food and in house dust lowered the frequency of allergic disorders in the first year of life for high-risk children, pre-natally randomized to a prophylactic or control group (Arshad et al., 1992)
Serving cool-girl energy today? Give Breezeberry Energy a whirl
Its common risk factors include obesity, large tonsils, and endocrine disorders
Epub 2022 Nov 11
Professor Richard Weller, Professor of Medical Dermatology at the University of Edinburgh and Honorary Consultant Dermatologist, added, Atopic dermatitis, a lifelong condition without a cure, greatly benefits from the expanding range of biologic treatments like lebrikizumab, now reimbursed by NICE, thereby enhancing treatment options for patients. NICEs endorsement of lebrikizumab represents a pivotal development in the treatment landscape for moderate to severe Atopic Dermatitis, offering hope for improved quality of life for many affected individuals.
The UK has entered a new chapter in obesity treatment with the approval of the first GLP-1 tablet specifically licensed for weight management: Wegovy tablet (oral semaglutide)
